Please note Epocrates will no longer provide this CME offering after December 31, 2015. However this free offering will continue to be available directly from RealCME and there will be no interruption to your account, including credits, certificates and new course offerings.

Please directly access your account by clicking RealCME Health Professional and use the same email address to log in to your account that you have used with EpocratesCME. For security purposes, you will be asked to establish a new password.

Recognition, Diagnosis, and Management of Children and Adolescents with Hereditary Angioedema


Recognition, Diagnosis, and Management of Children and Adolescents with Hereditary Angioedema

Topic: Allergy/ Immunology
Relevant Terms: Allergy, Angioedema, Gastroenterology, Hereditary Angioedema, Pediatrics, Primary Care
Primary Audience: This activity has been designed to meet the educational needs of pediatricians; general and family physicians; and other healthcare providers involved in the management of pediatric patients with hereditary angioedema (HAE).
Launch Date: 04-Feb-14
Credits: AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: HAE Diagnosis and Management

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Recognize the most common symptoms of HAE to minimize delays in diagnosis in children and adolescents
  2. Describe appropriate therapies for both on-demand and prophylactic treatment of children and adolescents with HAE
  3. Explain strategies for observation, education, referral, and follow-up of patients receiving on-demand or prophylactic therapy for HAE


    Aleena Banerji, MD
    Assistant Professor of Medicine
    Harvard Medical School
    Assistant Training Program Director
    Massachusetts General Hospital
    Boston, Massachusetts
    Michael S. Blaiss, MD
    Clinical Professor
    Department of Pediatrics and Medicine
    University of Tennessee Health Sciences Center
    Memphis, Tennessee
    William R. Lumry, MD
    Clinical Professor
    Department of Internal Medicine/Allergy
    University of Texas
    Southwestern Medical School
    Private Practice
    Dallas, Texas
    Activity Length

    The estimated time required to complete this activity is 1.0 hour.

    Accreditation Statement

    Integrity Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    Credit Designation

    Integrity Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Disclosure of Conflicts of Interest (COI)
    Integrity Continuing Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent COI they may have as related to the content of this activity. All identified COI are thoroughly vetted by Integrity Continuing Education for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
    Sean Gregory, PhD
    Has no real or apparent conflicts of interest to report.

    Aleena Banerji, MD
    Consultant: Dyax, Shire
    Research: Dyax, Shire, ViroPharma
    Michael S. Blaiss, MD
    Has no real or apparent conflicts of interest to report.
    William R. Lumry, MD
    Consultant: CSL Behring, Dyax, Genentech, Meda, Novartis, Shire HGT, ViroPharma
    Speaker: Genentech, Meda, Novartis, Shire HGT, ViroPharma
    Research: ADMA, CSL Behring, Dyax, Forest Laboratories, Genentech, Green Cross, Kedron, Meda, Merck, Shinogi, Shire HGT, Teva, ViroPharma

    Disclosure of Unlabeled Use
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education and ViroPharma do not recommend the use of any agent outside of the labeled indications.
    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education and ViroPharma. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
    Directions to Learners
    There are no fees for participating and receiving CME credit for this activity. Participants must:
    • Read the learning objectives and faculty disclosures 
    • Complete the pretest
    • Study the educational activity
    • Complete the posttest and evaluation form
    A statement of credit will be issued upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better.

    For questions about the accreditation of this program, please contact Integrity Continuing Education, Inc. at (888) 255-1009 or

    Supported Browsers:
    Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
    Google Chrome 28.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
    Safari 5.0+ for Mac OSX 10.5 and above
    Supported Phones & Tablets:
    Android 4.0.3 and above
    iPhone/iPad with iOS 6.1 or above